Acadian Asset Management
KDNY

Acadian Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Acadian Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20,809
Closed -$323K – 2274
2021
Q1 		$323K Sell
20,809
-40,277
-66% -$657K ﹤0.01% 1339
2020
Q4 		$969K Sell
61,086
-99,464
-62% -$1.5M ﹤0.01% 999
2020
Q3 		$1.95M Buy
160,550
+430
+0.3% +$5.76K 0.01% 674
2020
Q2 		$1.85M Buy
160,120
+33,347
+26% +$460K 0.01% 763
2020
Q1 		$1.74M Buy
126,773
+7,516
+6% +$88.9K 0.01% 647
2019
Q4 		$704K Buy
119,257
+56,020
+89% +$304K ﹤0.01% 978
2019
Q3 		$335K Buy
63,237
+17,087
+37% +$113K ﹤0.01% 1188
2019
Q2 		$355K Sell
46,150
-3,039
-6% -$46.3K ﹤0.01% 1093
2019
Q1 		$979K Buy
49,189
+38,054
+342% +$664K ﹤0.01% 902
2018
Q4 		$147K Buy
+11,135
New +$222K ﹤0.01% 1183
2016
Q4 		– Sell
-16
Closed -$1K – 1803
2016
Q3 		$1K Sell
16
-44,190
-100% -$3.12M ﹤0.01% 1390
2016
Q2 		$2.5M Buy
44,206
+33,428
+310% +$2.03M 0.01% 483
2016
Q1 		$691K Buy
10,778
+10,762
+67,263% +$871K ﹤0.01% 701
2015
Q4 		$2K Hold
16
– – ﹤0.01% 1351
2015
Q3 		$2K Hold
16
– – ﹤0.01% 1264
2015
Q2 		$2K Buy
+16
New +$2.64K ﹤0.01% 1325

Other funds holding KDNY

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management's KDNY Position: Q2 2021 in Review

Acadian Asset Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2021, closing a stake of 20,809 shares — an estimated $323K sold.

Acadian Asset Management first reported a position in KDNY in Q2 2015 and held it in 16 quarters. The position peaked at $2.5M in Q2 2016. 89 funds tracked by Wall St. Rank hold KDNY as of Q2 2021.

  • Acadian Asset Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Acadian Asset Management sold 20,809 Chinook Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $323K.
  • Acadian Asset Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 16 quarters.
  • Acadian Asset Management's Chinook Therapeutics, Inc. Common Stock position peaked at $2.5M in Q2 2016.
  • 89 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Acadian Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.